CompletedPhase 3ketamine

Administration of Ketamine to Prevent the Post-operative Pain

Sponsored by Institut Bergonié

NCT ID
NCT00210210
Target Enrollment
230 participants
Start Date
2004-01-31
Est. Completion
2005-12-31

About This Study

The surgery of breast cancer is responsible for post-operative pain, needing in about 30% some morphine consumption; like that, the association of ketamine with general anaesthesia may decrease morphine's use and so its adverse effects. The purpose is to evaluate the analgesic effect of a receptor NMDA's antagonist ( ketamine)

Conditions Studied

Postoperative PainBreast Cancer

Interventions

  • Ketamine
  • Saline solution

Eligibility

Sex:FEMALE
Age:18 Years - 100 Years
Healthy Volunteers:No
View full eligibility criteria
Inclusion criteria:

* Patients 18 years older
* ASA class 1 or 2
* with surgery of breast cancer (mastectomy or tumorectomy)

Exclusion criteria:

.Kétamine hypersensitivity

* Major psychiatric disorders
* Major cardio-vascular disorders
* Major neurologic disorders
* Major ocular disorders
* Morphine in pre-operative period

Study Locations (1)

Institut Bergonié - Centre Régional de Luttre Contre le Cancer de Bordeaux et du Sud Ouest
Bordeaux, France

This trial is not recruiting

This study has completed enrollment. Check back for results or find similar trials.

Find recruiting trials
Data Source
ClinicalTrials.gov

Last updated from source